CSIMarket
 
Rafael Holdings Inc   (RFL)
Other Ticker:  
 
    Sector  Services    Industry Real Estate Operations
   Industry Real Estate Operations
   Sector  Services
 
Price: $1.6800 $0.01 0.599%
Day's High: $1.7 Week Perf: -3.45 %
Day's Low: $ 1.67 30 Day Perf: -2.89 %
Volume (M): 14 52 Wk High: $ 2.52
Volume (M$): $ 24 52 Wk Avg: $1.93
Open: $1.67 52 Wk Low: $1.44



 Market Capitalization (Millions $) 40
 Shares Outstanding (Millions) 24
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -7
 Cash Flow (TTM) (Millions $) -10
 Capital Exp. (TTM) (Millions $) 0

Rafael Holdings Inc
Rafael Holdings Inc is a diversified company that owns and operates real estate properties and invests in healthcare assets. It is a subsidiary of IDT Corporation, a multinational holding company. Rafael Holdings primarily focuses on the ownership and management of real estate properties, specializing in commercial and residential spaces. The company also holds a stake in Rafael Pharmaceuticals, a clinical-stage cancer metabolism-based therapeutics company. Overall, Rafael Holdings Inc aims to generate revenue through its real estate properties and investment portfolio.


   Company Address: 520 Broad Street Newark 7102 NJ
   Company Phone Number: 658-1450   Stock Exchange / Ticker: NYSE RFL
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Rafael Holdings Inc

Rafael Holdings Inc Faces Unexpected Setback in First Quarter of 2024 with Revenue Decline and Deficit Per Share

Rafael Holdings Inc, a company operating in the first quarter of 2024 earnings season, experienced a slip into a deficit of $-0.15 per share compared to the previous year's $0.07 per share. This decline in earnings per share was also evident when compared to the prior quarter's $0.04 per share.
The company's revenue for the first quarter decreased by approximately -2.857%, totaling $0.07 million, compared to the $0.07 million revenue from the comparable quarter of the previous year. However, sequentially, the revenue remained unchanged at $0.07 million. It is worth noting that this marks a substantial decrease compared to the earnings of $1.493 million reported in the same quarter a year prior.
One significant signal for the company's performance is the increase in accounts receivable, which indicates a rising demand. The accounts receivable were valued at $2.1 million, higher than the preceding quarter. This suggests that Rafael Holdings Inc has been successful in generating demand for its products or services.

Rafael Holdings Inc

Rafael Holdings Inc Shines with Remarkable Turnaround, Achieving $1.191 Million in Fourth Quarter Earnings for 2023

Rafael Holdings Inc, the Real Estate Operations company, has shown significant improvements in its financial performance over the past year. In the reporting period from May to July 31, 2023, the company turned around its fortunes by displaying a surplus of $0.04 per share in Income, compared to a loss of $7.11 per share in the previous year. Additionally, revenue decreased by -4.225% to $0.07 million, while income per share turned positive at $0.06.
The fourth quarter of the 2023 earnings season proved to be a turning point for Rafael Holdings Inc, as the company recorded earnings of $1.191 million. This marks a substantial improvement from a net deficit of $-4.853 million in the same reporting period a year ago. Furthermore, the company's accounts receivable declined to $0.6 million compared to the previous quarter, although it is still higher than the same time a year ago.

Rafael Holdings Inc

Rafael Holdings Battles Meteoric Revenue Plunge in Intense Fiscal Quarter of 2023

Rafael Holdings Inc is a diversified holding company that operates in the biotechnology and pharmaceutical sectors. Its subsidiaries include Rafael Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, and EBO2 LLC, a medical technology company that focuses on the immune system.
In the most recent fiscal period, Rafael Holdings Inc reported a reduction in loss per share from $-0.28 a year ago to $-0.06 per share. This improvement in earnings per share is a positive sign for the company's financial health and suggests that its operations have become more efficient over time.
However, the company's revenue fell sharply by -91.886 % to $0.07 million from $0.88 million in the same financial reporting period a year ago. This decline in revenue can mainly be attributed to the impact of the COVID-19 pandemic, which has disrupted the global economy and affected the healthcare industry. Despite this setback, the company witnessed a sequential revenue surge of 1.429 % from $0.07 million, which is encouraging and indicates that Rafael Holdings Inc is adapting to the new normal.
Moreover, Rafael Holdings Inc reported a net deficit of $-1.490 million in the latest fiscal period, as compared to a deficit of $-5.548 million in the same financial reporting period a year ago. This reduction in net deficit is a positive sign for the company and demonstrates its efforts to streamline its operations and increase profitability.






 

Rafael Holdings Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com